SCHEMBL29352531

SCHEMBL29352531

Clc1cccc(Cl)c1NC1=NCCCN1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 11/20 0.81
ADRA2B P18089 8/20 0.81
ADRA2C P18825 8/20 0.81
LMNA P02545 5/20 0.81
ADRA1A P35348 4/20 0.81
ADRA1D P25100 3/20 0.81
ADRA1B P35368 3/20 0.81
NISCH Q9Y2I1 3/20 0.81
CYP2D6 P10635 3/20 0.81
HRH2 P25021 2/20 0.81
HIF1A Q16665 2/20 0.81
MEN1 O00255 1/20 0.81
SLC22A1 O15245 1/20 0.81
SLC22A3 O75751 1/20 0.81
HTR1A P08908 1/20 0.81
CYP2C9 P11712 1/20 0.81
CYP2C19 P33261 1/20 0.81
OPRK1 P41145 1/20 0.81
KMT2A Q03164 1/20 0.81
SLC47A1 Q96FL8 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clonidine SCHEMBL5983 0.90 ADRA2A (1.00) ADRA2AADRA2BADRA2CLMNAADRA1A
Clonidine SCHEMBL40752 0.88 ADRA2A (1.00) ADRA2AADRA2BADRA2CLMNAADRA1A
Clonidine SCHEMBL9838990 0.88 ADRA2A (0.97) ADRA2AADRA2BADRA2CLMNAADRA1A
Clonidine SCHEMBL2231324 0.88 ADRA2A (1.00) ADRA2AADRA2BADRA2CLMNAADRA1A
Clonidine SCHEMBL613364 0.88 ADRA2A (0.97) ADRA2AADRA2BADRA2CLMNAADRA1A
Clonidine SCHEMBL18050245 0.81 ADRA2A (0.82) ADRA2AADRA2BADRA2CLMNAADRA1A
SCHEMBL11176814 0.80 ADRA2A (0.79) ADRA2AADRA2BADRA2CLMNAADRA1A
SCHEMBL9920135 0.80 ADRA2A (0.79) ADRA2AADRA2BADRA2CLMNAADRA1A
SCHEMBL12225936 0.80 ADRA2A (0.79) ADRA2AADRA2BADRA2CLMNAADRA1A
SCHEMBL10972914 0.79 ADRA2A (0.52) ADRA2AADRA2BADRA2CLMNAADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114656572-B BP180 antibody rapid detection kit and preparation method thereof 北京大学第一医院 2024-07-19 CN claimed
CN-117447830-A Static-conductive anti-explosion polyurea elastomer composition, static-conductive anti-explosion polyurea elastomer, preparation method and application thereof 中国石油化工股份有限公司 2024-01-26 CN claimed
EP-3466061-B1 IMAGE PROJECTION SYSTEM AND IMAGE PROJECTION METHOD PANASONIC IP MAN CO LTD (JP) 2023-04-19 EP claimed
CN-115379629-B Automatic lighting system for gas station 徐州华宝能源科技有限公司 2023-01-17 CN claimed
CN-115379629-A Automatic lighting system for gas station 徐州华宝能源科技有限公司 2022-11-22 CN claimed
CN-114656572-A BP180 antibody rapid detection kit and preparation method thereof 北京大学第一医院 2022-06-24 CN claimed
WO-2026103507-A1 OPTICAL COMMUNICATION MODULE, OPTICAL COMMUNICATION SYSTEM, OPTICAL COMMUNICATION METHOD, AND VEHICLE 比亚迪股份有限公司 2026-05-21 WO disclosed
US-20260140872-A1 MEMORY SYSTEM AND MEMORY DEVICE KIOXIA CORPORATION (JP) 2026-05-21 US disclosed
CN-122052920-A Optical communication module, optical communication system, optical communication method, and vehicle 比亚迪股份有限公司 2026-05-15 CN disclosed
CN-122056127-A Substrate processing method and substrate processing system 东京毅力科创株式会社 2026-05-15 CN disclosed
WO-2026100711-A1 IMAGE FORMING SYSTEM キヤノンファインテックニスカ株式会社 2026-05-15 WO disclosed
EP-4738246-A1 REGISTRATION DEVICE, REGISTRATION METHOD, RECOGNITION DEVICE, RECOGNITION METHOD, AND PROGRAM Panasonic Intellectual Property Management Co., Ltd. (JP) 2026-05-06 EP disclosed
EP-4735500-A1 MULTI-COATING SYSTEM FOR COMPOSITE VESSELS Huntsman International LLC (US) 2026-05-06 EP disclosed
CN-114045104-A Preparation method of flame-retardant high-performance flexible explosion-proof coating 师海峰 2022-02-15 CN disclosed
US-20220044221-A1 CLEARING AND SETTLEMENT DEVICE, AND UNMANNED STORE SYSTEM PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2022-02-10 US disclosed
EP-3949838-A1 SLEEP STATE DETECTION DEVICE, SLEEP STATE DETECTION METHOD, AND SLEEP STATE DETECTION PROGRAM Teijin Limited (JP) 2022-02-09 EP disclosed
CN-114026890-A Roadside device and communication congestion control method 松下知识产权经营株式会社 2022-02-08 CN disclosed
US-20220036923-A1 MAGNETIC DISK DEVICE TOSHIBA KK (JP) 2022-02-03 US disclosed
EP-3941953-A1 TWO COMPONENT COATING COMPOSITIONS PPG Industries Ohio Inc. (US) 2022-01-26 EP disclosed
EP-3235477-B1 INFORMATION PROCESSING DEVICE, SURGICAL MICROSCOPE SYSTEM AND INFORMATION PROCESSING METHOD SONY GROUP CORP (JP) 2022-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260140872-A1 MEMORY SYSTEM AND MEMORY DEVICE CACNA1S, CACNA1C, CACNA2D1 ADRA2A 2741/4885ADRA2B 3729/4885ADRA2C 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.